You Brexit, You Buy It – Europe and the New Regulatory – Part 1 of 2 By Lynn Hansen, Director of Clinical and Regulatory Affairs, Pharmatech Associates With Brexit looming, questions and concerns hover like a grey cloud over the UK pharmaceutical industry. Industry insiders and colleagues in London found that the confusion surrounding what…
Hurry Up and Wait: Brexit from a Regulatory Point of View – Part 2
You Brexit, You Buy It – Europe and the New Regulatory – Part 2 By Lynn Hansen, Director of Clinical and Regulatory Affairs, Pharmatech Associates In Brexit Part 1, I expressed my Brexit thoughts as Theresa May was providing a tearful resignation and now the United Kingdom has the return of an energetic Boris Johnson,…